Literature DB >> 10408433

Alzheimer's disease. Antibody clears senile plaques.

P H St George-Hyslop, D A Westaway.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10408433     DOI： 10.1038/22006

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  5 in total

1.  Premorbid cognitive testing predicts the onset of dementia and Alzheimer's disease better than and independently of APOE genotype.

Authors:  J Cervilla; M Prince; S Joels; S Lovestone; A Mann
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-08       Impact factor: 10.154

Review 2.  Beta-amyloid production, aggregation, and clearance as targets for therapy in Alzheimer's disease.

Authors:  Fernanda G De Felice; Sérgio T Ferreira
Journal:  Cell Mol Neurobiol       Date:  2002-12       Impact factor: 5.046

Review 3.  New developments in animal models of Alzheimer's disease.

Authors:  C Janus; A L Phinney; M A Chishti; D Westaway
Journal:  Curr Neurol Neurosci Rep       Date:  2001-09       Impact factor: 5.081

Review 4.  EGFRvIII-targeted vaccination therapy of malignant glioma.

Authors:  Bryan D Choi; Gary E Archer; Duane A Mitchell; Amy B Heimberger; Roger E McLendon; Darell D Bigner; John H Sampson
Journal:  Brain Pathol       Date:  2009-10       Impact factor: 6.508

5.  Analysis of immune-related key genes in Alzheimer's disease.

Authors:  You Wu; Shunli Liang; Hong Zhu; Yaping Zhu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.